Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Norfloxacin Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112824388B reveals a novel norfloxacin propenone derivative with enhanced solubility and potent anti-tumor activity, offering a scalable route for pharmaceutical intermediates.